Immunologic competence of alveolar cells. II. Modification of the plaque-forming response by inhibitors, tolerance, and chronic stimulation.
D000818:Animals; D000917:Antibody Formation; D000921:Antibody-Producing Cells; D000937:Antigen-Antibody Reactions; D000961:Antilymphocyte Serum / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004912:Erythrocytes; D006168:Guinea Pigs; D006462:Hemolytic Plaque Technique; D007106:Immune Sera / Q000494:pharmacology; D007108:Immune Tolerance; D007136:Immunoglobulins; D008623:Mercaptoethanol / Q000494:pharmacology; D011650:Pulmonary Alveoli / Q000276:immunology*; D011691:Puromycin / Q000494:pharmacology; D011817:Rabbits; D012709:Serum Albumin; D012756:Sheep
D000961:Antilymphocyte Serum; D007106:Immune Sera; D007136:Immunoglobulins; D012709:Serum Albumin; D003609:Dactinomycin; D011691:Puromycin; D008623:Mercaptoethanol